HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Germana Bancone Selected Research

Enzymes

9/2022Genetic Variants of Glucose-6-Phosphate Dehydrogenase and Their Associated Enzyme Activity: A Systematic Review and Meta-Analysis.
1/2021G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs.
3/2018Primaquine-induced haemolysis in females heterozygous for G6PD deficiency.
9/2017Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers.
11/2013G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests.
3/2013Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report.
1/2008High risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Germana Bancone Research Topics

Disease

37Glucosephosphate Dehydrogenase Deficiency
02/2024 - 01/2008
33Hemolysis
02/2024 - 01/2008
22Vivax Malaria
09/2023 - 01/2014
20Malaria
10/2023 - 10/2007
6Infections
01/2019 - 12/2010
3Kernicterus
01/2022 - 01/2018
2Jaundice (Icterus)
01/2022 - 01/2018
2Inborn Genetic Diseases (Disease, Hereditary)
01/2020 - 01/2018
2Parasitemia
01/2019 - 10/2018
2Neonatal Hyperbilirubinemia
01/2018 - 01/2018
2Falciparum Malaria (Plasmodium falciparum Malaria)
01/2016 - 12/2014
1Hepatitis E
02/2024
1Rupture
01/2022
1Neonatal Sepsis
01/2022
1Favism
01/2021
1Typhoid Fever (Typhoid)
01/2018

Drug/Important Bio-Agent (IBA)

35Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
10/2023 - 01/2008
32PrimaquineFDA Link
02/2024 - 12/2010
9tafenoquineIBA
10/2023 - 01/2017
8Antimalarials (Antimalarial Agents)IBA
10/2023 - 01/2014
7EnzymesIBA
09/2022 - 01/2008
7Chloroquine (Aralen)FDA LinkGeneric
10/2021 - 02/2017
78-aminoquinolineIBA
01/2018 - 03/2013
3BilirubinIBA
10/2023 - 01/2018
3artenimol (dihydroartemisinin)IBA
10/2021 - 02/2017
3piperaquineIBA
10/2021 - 02/2017
3DapsoneFDA Link
03/2018 - 01/2008
3Oxidants (Oxidizing Agents)IBA
01/2018 - 01/2008
2Hemoglobins (Hemoglobin)IBA
10/2023 - 12/2017
2ArtesunateIBA
10/2021 - 10/2018
2AntigensIBA
01/2008 - 10/2007
1Transaminases (Aminotransferases)IBA
02/2024
1Sickle HemoglobinIBA
10/2023
1beta-Globins (beta Globin)IBA
01/2022
1Anti-Bacterial Agents (Antibiotics)IBA
01/2022
1UridineIBA
01/2022
1artemisinin (artemisinine)IBA
01/2022
1Mefloquine (Lariam)FDA LinkGeneric
10/2021
1Lumefantrine Drug Combination Artemether (Coartem)FDA Link
10/2021
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
11/2020
1NADP (NADPH)IBA
02/2017
1Complementary DNA (cDNA)IBA
01/2008
1Transforming Growth Factor beta (TGF-beta)IBA
01/2008
1ChemokinesIBA
01/2008
1RNA (Ribonucleic Acid)IBA
01/2008
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2008
1Recombinant ProteinsIBA
10/2007
1Immunoglobulin G (IgG)IBA
10/2007

Therapy/Procedure

3Therapeutics
01/2022 - 01/2019
1Duration of Therapy
01/2019
1Secondary Prevention
01/2019
1Prenatal Care (Care, Prenatal)
01/2017
1Blood Transfusion (Blood Transfusions)
01/2008